Peptide Blood Tests UK: What to Monitor and Where to Get Tested

Whether you are using a licensed GLP-1 agonist prescribed by your doctor or exploring research peptides independently, regular blood monitoring is one of the most important safety measures available to you.

Why monitoring is essential:

1. Baseline establishment: Pre-peptide blood work establishes your normal values. Without a baseline, you cannot determine whether changes are caused by the peptide or were pre-existing

2. Early detection of problems: Many adverse effects of peptides — liver stress, kidney dysfunction, metabolic changes — produce blood marker changes before symptoms appear. Catching these early allows timely intervention

3. Efficacy tracking: Blood tests can confirm whether the peptide is producing the intended physiological effects (e.g. HbA1c reduction with GLP-1 agonists)

4. Dose optimisation: Blood marker trends help determine whether a dose increase or decrease is appropriate

5. Medical record: Having documented blood work creates a medical record that can be invaluable if you ever need medical attention

How often to test:

• •Baseline: Before starting any peptide — ideally 1–2 weeks prior
• •Initial monitoring: 4–6 weeks after starting or changing dose
• •Ongoing: Every 3–6 months during stable use
• •If symptomatic: Immediately if you experience unexpected symptoms

A note on GP disclosure: The most valuable approach is to be honest with your GP about what you are taking. GPs have a duty of confidentiality and are interested in your safety, not in reporting you. If you are using research peptides and feel uncomfortable disclosing this, you still need monitoring — private blood testing is an alternative, but it is always better to have a healthcare professional interpreting your results.

Paying for private blood tests is a reasonable cost of responsible peptide use. Think of it as an essential expense, not an optional extra.

The specific tests you need depend on which peptides you are using, but the following panels cover the most important markers for the majority of peptide users.

Core panel (recommended for all peptide users):

1. Full Blood Count (FBC): - Haemoglobin, white blood cells, platelets - Detects anaemia, infection, and blood disorders - Baseline comparison is essential

2. Liver Function Tests (LFTs): - ALT, AST, ALP, GGT, bilirubin, albumin - Critical for detecting hepatotoxicity - Some peptides are metabolised by the liver; elevated enzymes indicate stress - ALT and AST are the most sensitive markers for liver cell damage

3. Kidney Function: - Creatinine, eGFR, urea - Peptides are often cleared through the kidneys - Dehydration from GLP-1 agonist side effects can stress the kidneys - eGFR below 60 requires medical attention

4. Metabolic Panel: - Fasting glucose and HbA1c - Essential for GLP-1 agonist users (tracks diabetes markers) - Some peptides (GH secretagogues) can impair glucose tolerance

5. Lipid Profile: - Total cholesterol, HDL, LDL, triglycerides - Weight loss peptides should improve lipid profiles; worsening requires investigation

Additional tests by peptide type:

• •GH secretagogues (CJC-1295, ipamorelin): Add IGF-1 levels, fasting insulin, fasting glucose. IGF-1 confirms GH axis activation
• •GLP-1 agonists: Add amylase and lipase (pancreas markers), thyroid function (TSH, free T4)
• •BPC-157 / TB-500: Core panel is usually sufficient; add CRP (inflammation marker) if used for injury recovery
• •Thymosin-based peptides: Add full thyroid panel (TSH, free T3, free T4)

UK residents have several options for accessing blood tests, ranging from free NHS services to comprehensive private panels.

Option 1: Through your NHS GP (Free) - Your GP can order most of the tests listed above through NHS pathology - Advantages: Free, results go into your medical record, GP interprets results - Disadvantages: May need to justify each test; GPs may be reluctant to order tests for peptide monitoring specifically - Tip: Frame requests around health screening — "I'd like a general health check including liver and kidney function" rather than "I need monitoring because I'm taking peptides"

Option 2: NHS Health Check (Free, England only) - Available to adults aged 40–74 every 5 years - Covers cardiovascular risk, cholesterol, blood glucose, kidney function - Does not cover liver function or IGF-1 - Useful as a starting point but insufficient for comprehensive peptide monitoring

Option 3: Private blood testing companies (£50–£300)

Several reputable UK companies offer walk-in or home testing:

• •Medichecks: Wide range of panels, home finger-prick or venous draw at partner clinics. Comprehensive health panels from £99
• •Thriva: Home finger-prick tests with online results and GP commentary. Subscription model available
• •Forth: Sports and health-focused panels with detailed reporting
• •London Medical Laboratory: Laboratory-grade venous testing in London
• •Randox Health: Multiple UK locations, comprehensive panels

Option 4: Private GP consultation (£100–£300) - A private GP can order comprehensive blood work with full clinical context - Results include professional interpretation - More expensive but provides the most complete service

Cost comparison for a comprehensive peptide monitoring panel: - NHS GP: Free (if your GP agrees to order the tests) - Medichecks Ultimate Performance Panel: ~£199 - Thriva Advanced Health Check: ~£149 - Private GP + NHS pathology: £150–£250 (consultation) + lab fees

Practical recommendation: The most cost-effective approach is to request routine blood work through your NHS GP (liver, kidney, lipids, glucose, FBC) and supplement with private testing for specific markers (IGF-1, detailed thyroid) that your GP may not order.

Understanding what your blood test results mean is essential — but remember that interpretation should ideally be done by a qualified healthcare professional. The following guidance is for educational purposes.

Liver Function Tests (LFTs): - ALT (normal: 7–56 U/L): Mild elevations (up to 2x normal) are common and may not be concerning. Elevations above 3x normal require medical evaluation. Persistent elevation is more concerning than a single elevated reading - AST (normal: 10–40 U/L): Similar interpretation to ALT. Exercise can temporarily elevate AST - GGT (normal: 9–48 U/L): Sensitive to alcohol and certain medications - Action: If ALT or AST exceeds 3x normal, stop the peptide and consult a healthcare professional

Kidney Function: - Creatinine (normal: 59–104 μmol/L for men, 45–84 for women): Elevated creatinine may indicate kidney stress. Dehydration, high-protein diets, and creatine supplementation can all elevate creatinine - eGFR (normal: >90 mL/min): Values below 60 indicate impaired kidney function. Values 60–89 may be normal for some individuals but warrant monitoring - Action: eGFR below 60 requires medical evaluation; ensure adequate hydration

Metabolic Markers: - Fasting glucose (normal: 4.0–5.5 mmol/L): 5.5–6.9 indicates pre-diabetes; above 7.0 indicates diabetes - HbA1c (normal: below 42 mmol/mol / 6.0%): 42–47 indicates pre-diabetes; above 48 indicates diabetes - IGF-1 (age-dependent reference range): Elevated above the age-adjusted range may indicate excessive GH stimulation

What patterns to watch for: - Progressive worsening over successive tests (trending in the wrong direction) - Sudden large changes from your baseline - Multiple markers moving in concerning directions simultaneously - Results outside the reference range that do not have an obvious explanation (e.g. dehydration, recent exercise)

When to seek medical attention immediately: - ALT or AST above 5x the upper limit of normal - eGFR below 30 - Significantly elevated amylase or lipase (possible pancreatitis) - Severely abnormal blood counts

A structured monitoring schedule ensures you catch problems early and maintain a useful longitudinal record of your health markers.

Pre-peptide baseline (1–2 weeks before starting): - Full blood count - Liver function tests - Kidney function - Fasting glucose + HbA1c - Lipid profile - Thyroid function (TSH, free T4) - For GH peptides: IGF-1 - For GLP-1 agonists: Amylase, lipase

First check (4–6 weeks after starting): - Liver function tests (most important at this stage) - Kidney function - Fasting glucose - Any peptide-specific markers

Second check (3 months): - Full panel as per baseline - Compare all values to your baseline - HbA1c is meaningful at this point (it reflects 3 months of blood sugar control)

Ongoing (every 3–6 months): - Core panel: LFTs, kidney function, fasting glucose, FBC - Full panel including lipids and HbA1c every 6 months - IGF-1 every 6 months for GH peptide users

Record keeping: - Create a simple spreadsheet tracking all results with dates - Note which peptide and dose you were on at each test - Record any symptoms or changes in wellbeing - Bring this record to any medical appointments

Cost budgeting: Assuming a mix of NHS and private testing: - Year 1: £200–£400 for comprehensive monitoring - Ongoing years: £100–£300 per year - Consider this a non-negotiable cost of peptide use

When to increase monitoring frequency: - During dose changes - If any results are borderline or mildly abnormal - If you add a new peptide to your protocol - If you develop new symptoms - If you have pre-existing liver, kidney, or metabolic conditions

*This guide is for educational purposes only. Blood test interpretation should be performed by a qualified healthcare professional. Abnormal results require medical evaluation — do not self-manage concerning blood work.*